Months after going public, Peninsula biotech Apexigen cuts staff, weighs its options for future
February 27, 2023 at 17:29 PM EST
The company ended last year with enough cash to last into third-quarter 2022.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|